Difference between revisions of "Example orders for Ipilimumab (Yervoy) in melanoma"
Jump to navigation
Jump to search
Warner-admin (talk | contribs) m (Text replacement - "'''Use of this site is subject to you reading and agreeing with the terms set forth" to "{|style="width: 100%; border-left:solid 20px #dc143c;border-right:solid 20px #dc143c;border-top:solid 20px #dc143c;border-bottom:solid 20px #dc143c;" align="center" | <span style="font-family:Arial; font-size:200%"> Hello!<br> We're happy that you've chosen to use HemOnc.org, and hope that you will return often. From now until January 31, we are conducting a survey to learn more about our users and how we can make the site better and more useful.<br> Please help us by filling it out!<br> '''Link:''' http://j.mp/2BlBaoQ </span> |}<br>'''Use of this site is subject to you reading and agreeing with the terms set forth") |
Warner-admin (talk | contribs) m (Text replacement - " " to " ") |
||
| (8 intermediate revisions by 2 users not shown) | |||
| Line 1: | Line 1: | ||
| − | + | <!--'''Use of this site is subject to you reading and agreeing with the terms set forth in the [[HemOnc.org_-_A_Hematology_Oncology_Wiki:General_disclaimer|disclaimer]]. If this is your first time visiting, we suggest you read the [[tutorial]].'''--> | |
| − | |||
| − | < | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
Remember that example order sets that may contain additional information about supportive medications, suggestions for monitoring, hydration, and pre-treatment screening information for chemotherapy regimens are purely anecdotal, provided only as examples of what some other providers may be using, and are typically not based on references in the primary literature. | Remember that example order sets that may contain additional information about supportive medications, suggestions for monitoring, hydration, and pre-treatment screening information for chemotherapy regimens are purely anecdotal, provided only as examples of what some other providers may be using, and are typically not based on references in the primary literature. | ||
| Line 20: | Line 13: | ||
'''12-week course''' | '''12-week course''' | ||
| − | ====Supportive | + | ====Supportive therapy==== |
*In case of hypersensitivity reaction, contact MD first, and then may use: | *In case of hypersensitivity reaction, contact MD first, and then may use: | ||
**Hydrocortisone (Cortef) 100 mg IV push | **Hydrocortisone (Cortef) 100 mg IV push | ||
| − | **Diphenhydramine (Benadryl) 50 mg IV push (only give if >6 hours from last dose | + | **Diphenhydramine (Benadryl) 50 mg IV push (only give if >6 hours from last dose) |
**Famotidine (Pepcid) 20 mg IV over 15 minutes | **Famotidine (Pepcid) 20 mg IV over 15 minutes | ||
**Epinephrine (EpiPen) 0.3 mg IM | **Epinephrine (EpiPen) 0.3 mg IM | ||
| Line 36: | Line 29: | ||
'''Clinical scenario & comments:''' | '''Clinical scenario & comments:''' | ||
| − | *65 year-old lady with locally advanced, recurrent melanoma after prior surgical resection. | + | *65 year-old lady with locally advanced, recurrent melanoma after prior surgical resection. No previous systemic therapy had been used. My institution includes all 4 doses of ipilimumab to be given over the 12-week course in a single order set. |
[[Category:Example chemotherapy order sets]] | [[Category:Example chemotherapy order sets]] | ||
Latest revision as of 01:58, 1 June 2023
Remember that example order sets that may contain additional information about supportive medications, suggestions for monitoring, hydration, and pre-treatment screening information for chemotherapy regimens are purely anecdotal, provided only as examples of what some other providers may be using, and are typically not based on references in the primary literature.
Ipilimumab (Yervoy)
Original references may be found at Ipilimumab (Yervoy)
Example regimen #1
- Ipilimumab (Yervoy) 3 mg/kg IV on days 1, 22, 43, 64
- Infuse via non-pyrogenic, low-protein-binding in-line filter. Requires a post infusion flush with NS or D5 after each infusion
12-week course
Supportive therapy
- In case of hypersensitivity reaction, contact MD first, and then may use:
- Hydrocortisone (Cortef) 100 mg IV push
- Diphenhydramine (Benadryl) 50 mg IV push (only give if >6 hours from last dose)
- Famotidine (Pepcid) 20 mg IV over 15 minutes
- Epinephrine (EpiPen) 0.3 mg IM
Hydration:
- 500 ml NS at KVO rate. Use as running IV for chemotherapy infusion. Give up to 500 ml NS.
Monitoring:
- Prior to first dose, check hepatitis B & C, HIV, and pregnancy status, if appropriate
- Prior to each dose, check: CBC with differential, absolute lymphocyte count, platelets, sodium, potassium, chloride, bicarbonate, BUN, creatinine, glucose, calcium, alkaline phosphatase, SGOT (AST), SGPT (ALT), total bilirubin, direct bilirubin, albumin, total protein, LDH, uric acid, amylase, lipase, TSH, Free T4
- Vital signs should be checked every 15 minutes x 1 hour after the first dose of ipilimumab
Clinical scenario & comments:
- 65 year-old lady with locally advanced, recurrent melanoma after prior surgical resection. No previous systemic therapy had been used. My institution includes all 4 doses of ipilimumab to be given over the 12-week course in a single order set.